O'DAY DANIEL PATRICK (Chairman & CEO) sold 2.5% of their position (15K shares) of GILEAD SCIENCES, INC. on the open market
Open‑market sale worth $1.95M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 8/4/2026ACC: 0001638643-26-000028
DirectorOfficer· Chairman & CEO
Since Feb 2019
-15K
Net shares
Net seller
$1.95M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
15K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−6.70K
Price / share
$129.66
Trade value
$868.71K
% of position
1.1%
8/3/2026
607.13K→600.43K
Common Stock
Direct
Shares
−7.70K
Price / share
$130.80
Trade value
$1.01M
% of position
1.3%
8/3/2026
600.43K→592.73K
Common Stock
Direct
Shares
−600.00
Price / share
$131.34
Trade value
$78.81K
% of position
0.1%
8/3/2026
592.73K→592.13K
Total
Net shares
−15K
Net value
-$1.95M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/3/2026 | S · Sale | −6.70K | $129.66 | $868.71K | 1.1% | 607.13K | 600.43K |
| Common Stock Direct | 8/3/2026 | S · Sale | −7.70K | $130.80 | $1.01M | 1.3% | 600.43K | 592.73K |
| Common Stock Direct | 8/3/2026 | S · Sale | −600.00 | $131.34 | $78.81K | 0.1% | 592.73K | 592.13K |
| Total | −15K | -$1.95M | ||||||
Derivative Transactions0
No derivative transactions reported